LunaVax is building the LunaChain, an integrated vaccine access network designed to improve immunization delivery across Africa. The network combines microneedle vaccine patches, biometric ID tools, mobile delivery units, data visibility platforms, and local manufacturing to address systemic gaps in the last mile. The company is currently piloting microarray patch (MAP) delivery workflows with Harvard Medical School's GCSRT program across Lagos, Abuja, Adamawa, and Anambra states in Nigeria.
Funding
Funding not disclosed
Founders
Product
Problem
Across Africa, millions of children remain unvaccinated not because vaccines don't exist, but because delivery systems break down — cold-chain gaps, needle shortages, health worker deficits, and poor tracking undermine immunization efforts. The access problem is not just about supply; it is about fragile systems that fail to reliably move vaccines from central storage to the families who need them most.
Solution
LunaVax is building the LunaChain, a connected, multi-layered network for vaccine delivery that integrates tools, delivery models, and data to close gaps in access. The framework brings together microneedle vaccine patches, biometric ID tools, mobile delivery via vans and drones, data visibility platforms, and next-generation vaccine platforms to create a smarter last-mile system. The company is currently developing one of the first Phase III study designs for microarray patch (MAP) vaccine delivery in Nigeria, working with partners to assess usability, logistics, and system-readiness across Lagos, Abuja, Adamawa, and Anambra states. By piloting MAP workflows and integrating biometric tracking, LunaVax aims to build the evidence base needed for scalable, equitable rollout across the continent.
Target Audience
Primary partners are public health agencies, academic institutions, foundations, and socially driven businesses seeking to scale next-generation vaccine delivery tools; the company also works with clinics, funders, and health technology innovators across Africa.
Features
- Microneedle vaccine patches (MAPs): stamp-sized patches designed to replace painful injections and enable storage and transport in low-resource settings without traditional cold-chain requirements
- Biometric ID tools: patient tracking and continuity of care support for populations lacking formal birth records or identification
- Mobile delivery infrastructure: integration of vans and drones for flexible last-mile logistics beyond fixed clinics and central health centers
- Data visibility platforms: real-time dashboards providing clinics and partners visibility into deliveries, stock levels, and system performance for faster coordination and response
- Next-generation vaccine platform integration: plans to build toward RNA, saRNA, DNA, viral vector, and protein subunit vaccine platforms tailored to Africa's health priorities
- Africa-based manufacturing strategy: localization of production to reduce dependence on external supply chains